Olanzapine No Better Than Placebo for Borderline Personality Disorder
The Carlat Psychiatry Report, Volume 7, Number 2, February 2009
https://www.thecarlatreport.com/newsletter-issue/tcprv7n2/
Issue Links: Learning Objectives | Editorial Information
Topics: Personality Disorders
Section editor, Glen Spielmans, PhD
In a double-blind trial, 314 outpatients with borderline personality disorder were randomly assigned to receive olanzapine or placebo. After 12 weeks of treatment, both groups showed significant improvements in borderline symptoms; however, there was no difference between olanzapine and placebo on the primary outcome measure.
You can't view details of this content, please login or buy subscription here
Section editor, Glen Spielmans, PhD
Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies ertaining to this educational activity.